EFG Asset Management North America Corp. Has $2.44 Million Stock Holdings in Align Technology, Inc. $ALGN

EFG Asset Management North America Corp. lifted its holdings in shares of Align Technology, Inc. (NASDAQ:ALGNFree Report) by 67.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,451 shares of the medical equipment provider’s stock after purchasing an additional 7,852 shares during the period. EFG Asset Management North America Corp.’s holdings in Align Technology were worth $2,435,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Align Technology by 4.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,222 shares of the medical equipment provider’s stock worth $1,624,000 after buying an additional 469 shares in the last quarter. Focus Partners Wealth boosted its stake in Align Technology by 5.2% during the first quarter. Focus Partners Wealth now owns 3,062 shares of the medical equipment provider’s stock worth $486,000 after acquiring an additional 151 shares in the last quarter. Sivia Capital Partners LLC acquired a new stake in Align Technology in the second quarter worth $204,000. Farther Finance Advisors LLC increased its stake in Align Technology by 42.2% in the second quarter. Farther Finance Advisors LLC now owns 310 shares of the medical equipment provider’s stock valued at $59,000 after purchasing an additional 92 shares in the last quarter. Finally, Park Avenue Securities LLC raised its holdings in shares of Align Technology by 11.2% during the second quarter. Park Avenue Securities LLC now owns 2,668 shares of the medical equipment provider’s stock valued at $505,000 after purchasing an additional 269 shares during the period. Institutional investors and hedge funds own 88.43% of the company’s stock.

Align Technology Stock Down 0.4%

Shares of NASDAQ:ALGN opened at $167.04 on Wednesday. The business’s 50 day moving average is $159.35 and its 200 day moving average is $149.57. Align Technology, Inc. has a 12-month low of $122.00 and a 12-month high of $232.20. The stock has a market cap of $11.99 billion, a price-to-earnings ratio of 32.37, a PEG ratio of 1.88 and a beta of 1.83.

Align Technology (NASDAQ:ALGNGet Free Report) last issued its quarterly earnings data on Wednesday, October 29th. The medical equipment provider reported $2.61 earnings per share for the quarter, beating the consensus estimate of $2.38 by $0.23. Align Technology had a return on equity of 13.96% and a net margin of 9.50%.The business had revenue of $995.69 million for the quarter, compared to analysts’ expectations of $980.75 million. During the same period last year, the business earned $2.35 EPS. The business’s revenue was up 1.8% on a year-over-year basis. As a group, equities research analysts expect that Align Technology, Inc. will post 7.98 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages recently commented on ALGN. Leerink Partners boosted their target price on Align Technology from $189.00 to $210.00 and gave the company an “outperform” rating in a research report on Thursday, January 22nd. Needham & Company LLC reissued a “hold” rating on shares of Align Technology in a research note on Thursday, October 30th. UBS Group decreased their price objective on Align Technology from $160.00 to $155.00 and set a “neutral” rating for the company in a report on Thursday, October 16th. Stifel Nicolaus set a $200.00 target price on Align Technology in a research report on Thursday, October 30th. Finally, Weiss Ratings raised shares of Align Technology from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, January 16th. Six research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $176.82.

Get Our Latest Stock Analysis on ALGN

Align Technology Company Profile

(Free Report)

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.

See Also

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGNFree Report).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.